Trial intelligence / Profile preview

Opaganib versus placebo in hospitalized adults with severe COVID-19 pneumonia requiring supplemental oxygen

MOH_2020-09-29_009363Phase 2Completed

Sponsor
RedHill Biopharma
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of Opaganib, sponsored by RedHill Biopharma. Started Sep 2020; status: completed.

02

Drugs

Opaganib

Beyond the preview

Go deeper on MOH_2020-09-29_009363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2020-09-29_009363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call